Vascular access in cystic fibrosis - Does size matter?

Journal of Vascular Access

Volumn 6, Issue 2, 2005, Pages 72-75

  Carroll, Will D ^a,b   Anderson, M ^a   Reddy, R V ^a   Pantin, C ^a   Lenney, W ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b DERBYSHIRE CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Catheter; Cystic fibrosis; Vascular access; Venepuncture

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; COST CONTROL; CYSTIC FIBROSIS; HUMAN; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PATIENT CARE; SCHOOL CHILD; SURVIVAL RATE; VASCULAR ACCESS; VEIN PUNCTURE;

EID: 22944490519     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980500600205     Document Type: Article

References (5)

1. Cunningham S, McColm JR, Mallinson A, Boyd I, Marshall TG. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis. Pediatr Pulmonol 2003; 36: 43-8.
2. Bijttebier P, Vertommen H. The impact of previous experience on children's reactions to venepuncture. J Health Psychol 1998; 3: 39-46.
3. Martin AJ, Morris LL, Reece J, Ford VVTD, Cassey J, Goldblatt E. Totally implantable vascular access in treatment of cystic fibrosis. Lancet 1986; 2 (8501):293.
4. Deerojanawong J, Sawyer SM, Fink AM, Strokes KB, Robertson CF. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications. Thorax 1998; 53:285-9.
5. Roberts GW, Holmes MD, Staugas RE, Day RA, Finlay CF, Pitcher A. Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filters. Ann Pharmacother 1994; 28: 11-6.